Click for best price
Cancer Therapies Market Size, Share 2023
| Market size in 2022 |
US$ 46540 million
|
Forecast Market size by 2029 |
US$ 62440 million
|
| Growth Rate |
CAGR of 4.3% |
Number of Pages |
60 Pages |
Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer, such as pain.
This report aims to provide a comprehensive presentation of the global market for Cancer Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Therapies. This report contains market size and forecasts of Cancer Therapies in global, including the following market information:
Global Cancer Therapies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Therapies market was valued at US$ 46540 million in 2022 and is projected to reach US$ 62440 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominates the global cancer therapy market, owing to high prevalence of cancer in the region because of a sedentary lifestyle, along with launch and growing adoption of novel cancer therapy in the region.
We surveyed the Cancer Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Therapies Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Therapies Market Segment Percentages, by Type, 2022 (%)
Immunological and Vaccine Approaches
Antiproliferative Approaches
Photodynamic Therapy
Gene Therapy Approaches
Cell Cycle and Apoptosis Approaches
Global Cancer Therapies Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Therapies Market Segment Percentages, by Application, 2022 (%)
Hospital Use
Clinic Use
Household
Other
Global Cancer Therapies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Therapies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Therapies revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Therapies revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AstraZeneca
Bristol-Myers Squibb
Bayer AG
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Therapies, market overview.
Chapter 2: Global Cancer Therapies market size in revenue.
Chapter 3: Detailed analysis of Cancer Therapies company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Therapies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Therapies Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 46540 million
|
| Forecast Market size by 2029 |
US$ 62440 million
|
| Growth Rate |
CAGR of 4.3% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Therapies Overall Market Size
2.1 Global Cancer Therapies Market Size: 2022 VS 2029
2.2 Global Cancer Therapies Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Therapies Players in Global Market
3.2 Top Global Cancer Therapies Companies Ranked by Revenue
3.3 Global Cancer Therapies Revenue by Companies
3.4 Top 3 and Top 5 Cancer Therapies Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Therapies Players in Global Market
3.6.1 List of Global Tier 1 Cancer Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Therapies Market Size Markets, 2022 & 2029
4.1.2 Immunological and Vaccine Approaches
4.1.3 Antiproliferative Approaches
4.1.4 Photodynamic Therapy
4.1.5 Gene Therapy Approaches
4.1.6 Cell Cycle and Apoptosis Approaches
4.2 By Type - Global Cancer Therapies Revenue & Forecasts
4.2.1 By Type - Global Cancer Therapies Revenue, 2018-2023
4.2.2 By Type - Global Cancer Therapies Revenue, 2024-2029
4.2.3 By Type - Global Cancer Therapies Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Therapies Market Size, 2022 & 2029
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application - Global Cancer Therapies Revenue & Forecasts
5.2.1 By Application - Global Cancer Therapies Revenue, 2018-2023
5.2.2 By Application - Global Cancer Therapies Revenue, 2024-2029
5.2.3 By Application - Global Cancer Therapies Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Therapies Market Size, 2022 & 2029
6.2 By Region - Global Cancer Therapies Revenue & Forecasts
6.2.1 By Region - Global Cancer Therapies Revenue, 2018-2023
6.2.2 By Region - Global Cancer Therapies Revenue, 2024-2029
6.2.3 By Region - Global Cancer Therapies Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Therapies Revenue, 2018-2029
6.3.2 US Cancer Therapies Market Size, 2018-2029
6.3.3 Canada Cancer Therapies Market Size, 2018-2029
6.3.4 Mexico Cancer Therapies Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Therapies Revenue, 2018-2029
6.4.2 Germany Cancer Therapies Market Size, 2018-2029
6.4.3 France Cancer Therapies Market Size, 2018-2029
6.4.4 U.K. Cancer Therapies Market Size, 2018-2029
6.4.5 Italy Cancer Therapies Market Size, 2018-2029
6.4.6 Russia Cancer Therapies Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Therapies Market Size, 2018-2029
6.4.8 Benelux Cancer Therapies Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Therapies Revenue, 2018-2029
6.5.2 China Cancer Therapies Market Size, 2018-2029
6.5.3 Japan Cancer Therapies Market Size, 2018-2029
6.5.4 South Korea Cancer Therapies Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Therapies Market Size, 2018-2029
6.5.6 India Cancer Therapies Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Therapies Revenue, 2018-2029
6.6.2 Brazil Cancer Therapies Market Size, 2018-2029
6.6.3 Argentina Cancer Therapies Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Therapies Revenue, 2018-2029
6.7.2 Turkey Cancer Therapies Market Size, 2018-2029
6.7.3 Israel Cancer Therapies Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Therapies Market Size, 2018-2029
6.7.5 UAE Cancer Therapies Market Size, 2018-2029
7 Cancer Therapies Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Cancer Therapies Major Product Offerings
7.1.4 Amgen Cancer Therapies Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Cancer Therapies Major Product Offerings
7.2.4 AstraZeneca Cancer Therapies Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Cancer Therapies Major Product Offerings
7.3.4 Bristol-Myers Squibb Cancer Therapies Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Cancer Therapies Major Product Offerings
7.4.4 Bayer AG Cancer Therapies Revenue in Global Market (2018-2023)
7.4.5 Bayer AG Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd
7.5.1 F. Hoffmann-La Roche Ltd Company Summary
7.5.2 F. Hoffmann-La Roche Ltd Business Overview
7.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd Cancer Therapies Revenue in Global Market (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.6 GlaxoSmithKline PLC
7.6.1 GlaxoSmithKline PLC Company Summary
7.6.2 GlaxoSmithKline PLC Business Overview
7.6.3 GlaxoSmithKline PLC Cancer Therapies Major Product Offerings
7.6.4 GlaxoSmithKline PLC Cancer Therapies Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline PLC Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Cancer Therapies Major Product Offerings
7.7.4 Johnson & Johnson Cancer Therapies Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 Merck & Co. Inc.
7.8.1 Merck & Co. Inc. Company Summary
7.8.2 Merck & Co. Inc. Business Overview
7.8.3 Merck & Co. Inc. Cancer Therapies Major Product Offerings
7.8.4 Merck & Co. Inc. Cancer Therapies Revenue in Global Market (2018-2023)
7.8.5 Merck & Co. Inc. Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Cancer Therapies Major Product Offerings
7.9.4 Novartis AG Cancer Therapies Revenue in Global Market (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Company Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Cancer Therapies Major Product Offerings
7.10.4 Pfizer Inc. Cancer Therapies Revenue in Global Market (2018-2023)
7.10.5 Pfizer Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Therapies Market Opportunities & Trends in Global Market
Table 2. Cancer Therapies Market Drivers in Global Market
Table 3. Cancer Therapies Market Restraints in Global Market
Table 4. Key Players of Cancer Therapies in Global Market
Table 5. Top Cancer Therapies Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Therapies Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Therapies Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Therapies Product Type
Table 9. List of Global Tier 1 Cancer Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Therapies Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Therapies Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Therapies Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Therapies Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Therapies Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Therapies Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Therapies Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Therapies Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Therapies Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Therapies Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Therapies Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Therapies Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Therapies Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Therapies Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Therapies Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Therapies Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Cancer Therapies Product Offerings
Table 32. Amgen Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Cancer Therapies Product Offerings
Table 36. AstraZeneca Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Cancer Therapies Product Offerings
Table 40. Bristol-Myers Squibb Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Bayer AG Company Summary
Table 43. Bayer AG Cancer Therapies Product Offerings
Table 44. Bayer AG Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer AG Key News & Latest Developments
Table 46. F. Hoffmann-La Roche Ltd Company Summary
Table 47. F. Hoffmann-La Roche Ltd Cancer Therapies Product Offerings
Table 48. F. Hoffmann-La Roche Ltd Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 49. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 50. GlaxoSmithKline PLC Company Summary
Table 51. GlaxoSmithKline PLC Cancer Therapies Product Offerings
Table 52. GlaxoSmithKline PLC Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 53. GlaxoSmithKline PLC Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Cancer Therapies Product Offerings
Table 56. Johnson & Johnson Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Merck & Co. Inc. Company Summary
Table 59. Merck & Co. Inc. Cancer Therapies Product Offerings
Table 60. Merck & Co. Inc. Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 61. Merck & Co. Inc. Key News & Latest Developments
Table 62. Novartis AG Company Summary
Table 63. Novartis AG Cancer Therapies Product Offerings
Table 64. Novartis AG Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 65. Novartis AG Key News & Latest Developments
Table 66. Pfizer Inc. Company Summary
Table 67. Pfizer Inc. Cancer Therapies Product Offerings
Table 68. Pfizer Inc. Cancer Therapies Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Inc. Key News & Latest Developments
List of Figures
Figure 1. Cancer Therapies Segment by Type in 2022
Figure 2. Cancer Therapies Segment by Application in 2022
Figure 3. Global Cancer Therapies Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Therapies Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Therapies Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Therapies Revenue in 2022
Figure 8. By Type - Global Cancer Therapies Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Therapies Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Therapies Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Therapies Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Therapies Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Therapies Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Therapies Revenue Market Share, 2018-2029
Figure 16. US Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Therapies Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Therapies Revenue Market Share, 2018-2029
Figure 28. China Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Therapies Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Therapies Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Therapies Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer AG Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. F. Hoffmann-La Roche Ltd Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. GlaxoSmithKline PLC Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Merck & Co. Inc. Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novartis AG Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Inc. Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
